Skip to content
Wednesday, November 18, 2026
SilverSpin Platform offers cutting-edge AI tools for conten…

Users Discontinuing Slimming Medications Regain Pounds Four Times Faster Compared to People Using Diet and Exercise

Image of medical injection and weighing machine
Weight management involves ongoing approaches.

New research indicates that people who discontinue new GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who halt conventional lifestyle regimens.

Published data in a leading medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Individuals purchasing these medications should be cognizant of the risk of rapid weight regain when the treatment ends," warns researcher Dr. Susan Jebb.

Such speed of regain suggests a reversion to original weight within about 18 months.

Weighing Therapies

The analysis, which looked at dozens of studies involving over 9,000 of participants, contrasted the results of these new drugs with older methods.

Scientists emphasize that people who lose weight through lifestyle changes alone generally have a more gradual weight regain—approximately 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts propose the way of the drugs is key to understanding the accelerated rebound.

These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating far more likely."

A Lifelong Condition?

The NHS suggest the injections for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

Many experts contend that, due to the likelihood of weight regain, the treatment might need to be long-term.

This perspective is echoed by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

Users who have come off the medication describe a intense return of hunger.

"I experienced a trigger activating and you're instantly starving," recalled one woman.

This challenge is worsened if patients have not established permanent dietary or behavioural modifications during therapy.

Growing Interest

Survey data show that millions of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

  • Use is higher among females compared to men.
  • The 40s and 50s demographic shows the greatest usage rates.
  • Many access the medications through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a permanent fix and lasting health benefits relies on integrated lifestyle management.

Written by

Aaron Howard

A digital strategist with over a decade of experience in AI-driven content marketing and SEO optimization.

SilverSpin Platform

Type to search articles.